Prelude Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,532
| Closed | -$421K | – | 2497 |
|
|
2021
Q4 | $421K | Buy |
+4,532
| New | +$299K | 0.01% | 1121 |
|
|
2021
Q1 | – | Sell |
-3,403
| Closed | -$261K | – | 1924 |
|
|
2020
Q4 | $261K | Buy |
3,403
+1,489
| +78% | +$112K | 0.01% | 980 |
|
|
2020
Q3 | $143K | Buy |
1,914
+157
| +9% | +$10.5K | 0.01% | 786 |
|
|
2020
Q2 | $111K | Buy |
+1,757
| New | +$96.7K | 0.01% | 918 |
|
|
2017
Q3 | – | Sell |
-3,400
| Closed | -$57K | – | 1984 |
|
|
2017
Q2 | $57K | Sell |
3,400
-6,140
| -64% | -$84.2K | 0.01% | 967 |
|
|
2017
Q1 | $139K | Buy |
9,540
+6,170
| +183% | +$91.4K | 0.01% | 681 |
|
|
2016
Q4 | $48K | Buy |
3,370
+720
| +27% | +$11.2K | 0.01% | 1060 |
|
|
2016
Q3 | $46K | Sell |
2,650
-1,980
| -43% | -$32.8K | ﹤0.01% | 1066 |
|
|
2016
Q2 | $79K | Buy |
4,630
+3,070
| +197% | +$54.9K | 0.01% | 845 |
|
|
2016
Q1 | $31K | Sell |
1,560
-2,120
| -58% | -$34K | ﹤0.01% | 1051 |
|
|
2015
Q4 | $70K | Buy |
+3,680
| New | +$75.1K | 0.01% | 945 |
|
Prelude Capital Management's ARNA Position: Q1 2022 in Review
Prelude Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 4,532 shares — an estimated $421K sold.
Prelude Capital Management first reported a position in ARNA in Q4 2015 and held it in 11 quarters. The position peaked at $421K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Prelude Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Prelude Capital Management sold 4,532 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $421K.
- Prelude Capital Management first reported a position in Arena Pharmaceuticals Inc in Q4 2015 and held it in 11 quarters.
- Prelude Capital Management's Arena Pharmaceuticals Inc position peaked at $421K in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Prelude Capital Management's 13F filing for Q1 2022, filed 16 May 2022.